Email alerts
Advanced Search
Your search returned 655 results
  • Oct 26, 2011
    Medtronic Starts Landmark Study of Hypertension Treatment
    U.S. Clinical Trial of Symplicity(R) Renal Denervation System(TM) Enrolls First Patient

    MINNEAPOLIS, Oct 26, 2011 (BUSINESS WIRE) -- Medtronic Inc. (NYSE: MDT) announced today the start of SYMPLICITY HTN-3, the company's U.S. clinical trial of the Symplicity(R) Renal Denervation...

  • Sep 12, 2011
    Medtronic Announces Launch of ARTISAN(TM) Space Maintenance System
    New technology offers one-source, customizable option for bone grafting space maintenance in oral-maxillofacial applications

    MEMPHIS, Tenn., Sep 12, 2011 (BUSINESS WIRE) -- Medtronic, Inc. (NYSE:MDT) announced today the U.S. launch of its ARTISAN(TM) Space Maintenance System. The device is cleared for temporary use in...

  • Sep 8, 2011
    Medtronic Named to Dow Jones Sustainability World Index
    Index Acknowledge Corporate Sustainability Accomplishments

    MINNEAPOLIS, Sep 08, 2011 (BUSINESS WIRE) -- Recognizing its leadership in meeting the needs of economic, environmental, and social stakeholders, Medtronic, Inc. (NYSE: MDT) has been named a...

  • Aug 31, 2011
    Medtronic Completes Acquisitions of PEAK Surgical, Inc. and Salient Surgical Technologies, Inc.
    Medtronic Expands Role in Advanced Energy Surgical Technologies

    MINNEAPOLIS, Aug 31, 2011 (BUSINESS WIRE) -- Medtronic, Inc. (NYSE: MDT) today announced that it has completed the acquisition of two privately-held companies, PEAK Surgical, Inc. and Salient...

  • Aug 5, 2011
    Medtronic to Webcast Annual Shareholder Meeting

    MINNEAPOLIS, Aug 05, 2011 (BUSINESS WIRE) -- Medtronic investors and other interested parties are invited to participate in a live video webcast of the Medtronic Annual Shareholder Meeting on...

  • Jul 25, 2011
    Medtronic Resolute(R) Drug-Eluting Stent Shows Superiority to Taxus(R) DES in Study of Patients with Coronary Artery Disease
    Presented at CVIT by Principal Investigator Shigeru Saito, One-Year Data from RESOLUTE Japan Support Company's PMDA Submission for Product Approval

    MINNEAPOLIS, Jul 25, 2011 (BUSINESS WIRE) -- TheResolute(R) drug-eluting stent (DES) from Medtronic, Inc. (NYSE: MDT), showed superiority to Boston Scientific Corp.'s Taxus(R) DES on the primary...

  • Jul 11, 2011
    Medtronic Gets Go-Ahead from FDA for Study of Novel Treatment for High Blood Pressure
    Patient Enrollment in U.S. Clinical Trial of Renal Denervation with Symplicity(R) Catheter System(TM) for Treating Resistant Hypertension to Start Soon

    MINNEAPOLIS, Jul 11, 2011 (BUSINESS WIRE) -- Medtronic, Inc. (NYSE: MDT), announced today that the U.S. Food and Drug Administration (FDA) has conditionally approved the protocol for SYMPLICITY...

  • Jul 7, 2011
    Medtronic To Acquire Salient Surgical Technologies, Inc.
    Medtronic Targets Leadership Role in Advanced Energy Surgical Technologies

    MINNEAPOLIS, Jul 07, 2011 (BUSINESS WIRE) -- Medtronic, Inc. (NYSE: MDT) today announced that it has entered into a definitive agreement to acquire Salient Surgical Technologies, Inc., the leader...

  • Jul 7, 2011
    Medtronic To Acquire PEAK Surgical, Inc.
    Medtronic Targets Leadership Role in Advanced Energy Surgical Technologies

    MINNEAPOLIS, Jul 07, 2011 (BUSINESS WIRE) -- Medtronic, Inc. (NYSE: MDT) today announced that it has entered into a definitive agreement to acquire PEAK Surgical, Inc., a recognized leader in the...

  • Jun 23, 2011
    Medtronic Board Increases Cash Dividend by Eight Percent; Increases Share Repurchase Plan

    MINNEAPOLIS, Jun 23, 2011 (BUSINESS WIRE) -- The board of directors of Medtronic, Inc. (NYSE: MDT) today approved an eight percent increase in its cash dividend for fiscal year 2012, raising the...

Show 5102550100 per page